Inhibition of Ganciclovir-Susceptible and -Resistant Human Cytomegalovirus Clinical Isolates by the Benzimidazole l -Riboside 1263W94

Author:

McSharry James J.1,McDonough Ann1,Olson Betty1,Talarico Christine2,Davis Michele2,Biron Karen K.2

Affiliation:

1. Albany Medical College, Albany, New York,1 and

2. GlaxoSmithKline, Research Triangle Park, North Carolina2

Abstract

ABSTRACT The average 50% inhibitory concentration (IC 50 ) values for AD169 were 0.22 ± 0.09 μM 1263W94 and 5.36 ± 0.12 μM ganciclovir. For 35 human cytomegalovirus (HCMV) clinical isolates the average IC 50 was 0.42 ± 0.09 μM 1263W94, and for 26 ganciclovir-susceptible HCMV clinical isolates the average IC 50 was 3.78 ± 1.62 μM ganciclovir. Nine HCMV clinical isolates that were resistant to ganciclovir were completely susceptible to 1263W94.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Reference23 articles.

1. Britt W. J. Alford C. A. Cytomegalovirus P. 2493–2524. Fields virology 3rd ed. Fields B. N. Knipe D. M. Howley P. M. 1996 Lippincott-Raven Publishers Philadelphia Pa

2. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.;Chou S.;J. Infect. Dis.,1995

3. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates.;Chou S.;J. Infect. Dis.,1995

4. Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease.;Chulay J.;Adv. Exp. Med. Biol.,1999

5. Ganciclovir.;Crumpacker C.;N. Engl. J. Med.,1996

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3